Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, Lamivudine-resistant chronic hepatitis B patients

Hyun Wook Jung , Moon Seok Choi , Kap Hyun Kim , Sung Hyun Park , Keum Yeon Kwak , Joon Hyoek Lee , Kwang Cheol Koh , Seung Woon Paik , Byung Chul Yoo

Clin Mol Hepatol. 2009;15(1):52-58. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.52

Predictors of Lamivudine Resistance in Patients with Chronic Hepatitis B Virus Infection

Jeong Heo , Mong Cho , Byung Mann Cho , Sun Mi Lee , Tae Oh Kim , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song

Clin Mol Hepatol. 2007;13(2):157-165. Published online January 1, 1970

2

Resistance to Adefovir in Patients with Chronic Hepatitis B

Soo Hyung Ryu, M.D.,* Young-Hwa Chung, M.D.

Clin Mol Hepatol. 2006;12(4):484-492. Published online January 1, 2000

3

Comparison of Clinical Outcome Between Patients Continuing and Discontinuing Lamivudine Therapy in Acute Exacerbation After Viral breakthrough During Lamivudine Therapy in Chronic Hepatitis B

Jong Ryul Eun

Clin Mol Hepatol. 2006;12(2):184-190. Published online January 1, 1970

Correlation of HBV DNA Level and Viral Breakthrough During Lamivudine Therapy for Chronic Hepatitis B

Hee Seung Park , Dong Hyun Lee , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song , Mong Cho

Clin Mol Hepatol. 2006;12(2):173-183. Published online January 1, 1970

1 |

Viewed By 7033	Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Viewed By 4142	Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Viewed By 3637	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Viewed By 2826	KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Viewed By 2055	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Cited By 44	Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Cited By 33	Application of transient elastography in nonalcoholic fatty liver disease
Cited By 30	Novel biomarkers for the management of chronic hepatitis B
Cited By 30	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Cited By 29	Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

Search